Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF U.S. HEALTHCARE ANALYTICS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE U.S. HEALTHCARE ANALYTICS MARKET
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMAPANY MARKET SHARE ANALYSIS
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 STANDARDS OF MEASUREMENT
2.2.8 VENDOR SHARE ANALYSIS
2.2.9 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.10 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 U.S. HEALTHCARE ANALYTICS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHT
5.1 PORTERS FIVE FORCES
5.2 REGULATORY STANDARDS
5.3 TECHNOLOGICAL TRENDS
5.4 PATENT ANALYSIS
5.5 CASE STUDY
5.6 VALUE CHAIN ANALYSIS
5.7 COMPANY COMPARITIVE ANALYSIS
5.8 PRICING ANALYSIS
6 U.S. HEALTHCARE ANALYTICS MARKET, BY COMPONENT
6.1 OVERVIEW
6.2 HARDWARE
6.3 SOFTWARE
6.4 SERVICES
6.4.1 SUPPORT SERVICES
6.4.2 BUSINESS ANALYTICS SERVICES
7 U.S. HEALTHCARE ANALYTICS MARKET, BY TYPE
7.1 OVERVIEW
7.2 PRESCRIPTIVE ANALYTICS
7.3 PREDICTIVE ANALYTICS
7.4 DESCRIPTIVE ANALYTICS
7.5 COGNITIVE ANALYTICS
8 U.S. HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL
8.1 OVERVIEW
8.2 ON-DEMAND
8.3 ON-PREMISES
9 U.S. HEALTHCARE ANALYTICS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 CLINICAL ANALYTICS
9.2.1 REGULATORY REPORTING AND COMPLIANCE
9.2.2 QUALITY IMPROVEMENT AND CLINICAL BENCHMARKING
9.2.3 CLINICAL DECISION SUPPORT
9.2.4 COMPARATIVE ANALYTICS/ EFFECTIVENESS
9.2.5 PRECISION HEALTH
9.3 POPULATION HEALTH ANALYTICS
9.3.1 POPULATION CARE MANAGEMENT
9.3.2 POPULATION RISK MANAGEMENT
9.3.3 CLINICAL OUTCOME MANAGEMENT
9.3.4 ACTIVITY-BASED COSTING
9.4 FINANCIAL ANALYTICS
9.4.1 PAYMENT INTEGRITY AND FRAUD, WASTE, AND ABUSE (FWA)
9.4.2 REVENUE CYCLE MANAGEMENT (RCM)
9.4.3 RISK ADJUSTMENT AND RISK ASSESSMENT
9.4.4 CLAIMS PROCESSING
9.5 OPERATIONAL AND ADMINISTRATIVE ANALYTICS
9.5.1 SUPPLY CHAIN ANALYTICS
9.5.2 WORKFORCE ANALYTICS
9.5.3 RESEARCH ANALYTICS
9.5.4 MARKET INTELLIGENCE
9.5.5 ENTERPRISE PERFORMANCE
9.5.6 STRATEGIC ANALYTICS
10 U.S. HEALTHCARE ANALYTICS MARKET, BY END USER
10.1 OVERVIEW
10.2 HEALTHCARE PAYERS
10.2.1 GOVERNMENT AGENCIES
10.2.2 PRIVATE INSURANCE COMPANIES
10.2.3 EMPLOYERS AND PRIVATE EXCHANGES
10.3 HEALTHCARE PROVIDERS
10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS
10.3.2 AMBULATORY SETTINGS
10.3.3 POST-ACUTE CARE ORGANIZATIONS
10.4 ACCOUNTABLE CARE ORGANIZATIONS (ACOS)
10.5 MANAGED CARE ORGANIZATION (MCOS)
10.6 TPAS (THIRD PARTY ADMINISTRATOR)
10.7 OTHERS
11 U.S. HEALTHCARE ANALYTICS MARKET,COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: U.S.
11.2 MERGERS & ACQUISITIONS
11.3 NEW PRODUCT DEVELOPMENT AND APPROVALS
11.4 EXPANSIONS
11.5 REGULATORY CHANGES
11.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12 U.S. HEALTHCARE ANALYTICS MARKET, SWOT & DBMR ANALYSIS
13 U.S. HEALTHCARE ANALYTICS MARKET, COMPANY PROFILE
13.1 SISENSE LTD
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENT
13.2 INFOSYS LIMITED
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 PRODUCT PORTFOLIO
13.2.4 RECENT DEVELOPMENT
13.3 ARCADIA SOLUTIONS, LLC. (A PART OF POHLAD COMPANIES)
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT DEVELOPMENT
13.4 ORACLE
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 PRODUCT PORTFOLIO
13.4.4 RECENT DEVELOPMENT
13.5 SAS INSTITUTE INC
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENT
13.6 SNOWFLAKE INC
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENT
13.7 THOUGHTSPOT INC.
13.7.1 COMPANY SNAPSHOT
13.7.2 REVENUE ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENT
13.8 ALTERYX
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENT
13.9 OPTUM, INC (A PART OF UNITEDHEALTH GROUP INC)
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENT
13.1 CITIUSTECH HEALTHCARE TECHNOLOGY PRIVATE LIMITED
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT DEVELOPMENT
13.11 WIPRO
13.11.1 COMPANY SNAPSHOT
13.11.2 REVENUE ANALYSIS
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT DEVELOPMENT
13.12 EXLSERVICE HOLDINGS, INC
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT DEVELOPMENT
13.13 HEALTH CATALYST
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENT
13.14 IBM
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENT
13.15 SALESFORCE, INC.
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENT
13.16 CLARIFY HEALTH SOLUTIONS
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENT
13.17 QLIKTECH INTERNATIONAL AB,
13.17.1 COMPANY SNAPSHOT
13.17.2 REVENUE ANALYSIS
13.17.3 PRODUCT PORTFOLIO
13.17.4 RECENT DEVELOPMENT
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
14 CONCLUSION
15 QUESTIONNAIRE
16 RELATED REPORTS
17 ABOUT DATA BRIDGE MARKET RESEARCH
